BOYER ANDREW S 4
4 · Amneal Pharmaceuticals, Inc. · Filed Aug 22, 2025
Insider Transaction Report
Form 4
BOYER ANDREW S
Executive Vice President
Transactions
- Exercise/Conversion
Class A Common Stock
2025-08-20$2.75/sh+175,000$481,250→ 431,670 total - Sale
Class A Common Stock
2025-08-20$9.38/sh−279,244$2,619,309→ 152,426 total - Exercise/Conversion
Stock Option
2025-08-20−175,000→ 97,480 totalExercise: $2.75→ Class A Common Stock (175,000 underlying)
Footnotes (2)
- [F1]The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.40 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
- [F2]These options are fully vested.